Literature DB >> 7429678

Influence of route of administration on haloperidol plasma levels in psychotic patients.

G Bianchetti, E Zarifian, M F Poirier-Littre, P L Morselli, P Deniker.   

Abstract

Haloperidol plasma concentrations were determined in psychotic patients to whom the drug was given by three different routes of administration (i. v. perfusion, intramuscularly and orally). When measured 15 hours after the last administration, a significant difference (p < 0,001) was found in the steady state plasma concentration between the oral and the i.m. route. The values were higher after intramuscular administration and were subject to less interindividual fluctuation than after the oral. The reduction in plasma levels after oral administration in respect to i.m. were in accordance with the bioavailability of haloperidol. The opportunity of switching from oral to intramuscular treatment is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429678

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  4 in total

Review 1.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 2.  Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis.

Authors:  R Beresford; A Ward
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

Review 3.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

Review 4.  Pharmacokinetic optimisation of the treatment of psychosis.

Authors:  A E Balant-Gorgia; L P Balant; A Andreoli
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.